Selected research
Industry Research
Veterinary Biologics Industry Research Report 2026
Market perspective
The global Veterinary Biologics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veterinary Biologics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Veterinary Biologics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veterinary Biologics include Avimex Animal, Bio-Labs, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, DHN, Elanco/Eli Lilly and FATRO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veterinary Biologics market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Biologics Market by Company
Avimex Animal
Bio-Labs
Boehringer Ingelheim
CAHIC
CAVAC
Ceva
DHN
Elanco/Eli Lilly
FATRO
HVRI
Kyoto Biken
Ringpu Biology
Vaksindo
Virbac
WINSUN
Yebio
Zoetis
ChengDu Tecbond
Jinyu Bio-Technology
Merck
Veterinary Biologics Segment by Type
Vaccines
Monoclonal Antibodies
Veterinary Biologics Segment by Application
Llivestock
Equine
Other
Veterinary Biologics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Biologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Biologics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccines
- Monoclonal Antibodies
Applications
- Llivestock
- Equine
- Other
Companies covered
- Avimex Animal
- Bio-Labs
- Boehringer Ingelheim
- CAHIC
- CAVAC
- Ceva
- DHN
- Elanco/Eli Lilly
- FATRO
- HVRI
- Kyoto Biken
- Ringpu Biology
- Vaksindo
- Virbac
- WINSUN
- Yebio
- Zoetis
- ChengDu Tecbond
- Jinyu Bio-Technology
- Merck
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Biologics Market Size (2021-2032)
- 2.2.2 Global Veterinary Biologics Sales (2021-2032)
- 2.2.3 Global Veterinary Biologics Market Average Price (2021-2032)
- 2.3 Veterinary Biologics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vaccines
- 2.3.3 Monoclonal Antibodies
- 2.4 Veterinary Biologics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Llivestock
- 2.4.3 Equine
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Biologics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Biologics Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Biologics Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Biologics Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Biologics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Biologics, Product Type & Application
- 3.8 Global Manufacturers of Veterinary Biologics, Established Date
- 3.9 Global Veterinary Biologics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Avimex Animal
- 4.1.1 Avimex Animal Company Information
- 4.1.2 Avimex Animal Business Overview
- 4.1.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Avimex Animal Veterinary Biologics Product Portfolio
- 4.1.5 Avimex Animal Recent Developments
- 4.2 Bio-Labs
- 4.2.1 Bio-Labs Company Information
- 4.2.2 Bio-Labs Business Overview
- 4.2.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bio-Labs Veterinary Biologics Product Portfolio
- 4.2.5 Bio-Labs Recent Developments
- 4.3 Boehringer Ingelheim
- 4.3.1 Boehringer Ingelheim Company Information
- 4.3.2 Boehringer Ingelheim Business Overview
- 4.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
- 4.3.5 Boehringer Ingelheim Recent Developments
- 4.4 CAHIC
- 4.4.1 CAHIC Company Information
- 4.4.2 CAHIC Business Overview
- 4.4.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CAHIC Veterinary Biologics Product Portfolio
- 4.4.5 CAHIC Recent Developments
- 4.5 CAVAC
- 4.5.1 CAVAC Company Information
- 4.5.2 CAVAC Business Overview
- 4.5.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CAVAC Veterinary Biologics Product Portfolio
- 4.5.5 CAVAC Recent Developments
- 4.6 Ceva
- 4.6.1 Ceva Company Information
- 4.6.2 Ceva Business Overview
- 4.6.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ceva Veterinary Biologics Product Portfolio
- 4.6.5 Ceva Recent Developments
- 4.7 DHN
- 4.7.1 DHN Company Information
- 4.7.2 DHN Business Overview
- 4.7.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 DHN Veterinary Biologics Product Portfolio
- 4.7.5 DHN Recent Developments
- 4.8 Elanco/Eli Lilly
- 4.8.1 Elanco/Eli Lilly Company Information
- 4.8.2 Elanco/Eli Lilly Business Overview
- 4.8.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
- 4.8.5 Elanco/Eli Lilly Recent Developments
- 4.9 FATRO
- 4.9.1 FATRO Company Information
- 4.9.2 FATRO Business Overview
- 4.9.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 FATRO Veterinary Biologics Product Portfolio
- 4.9.5 FATRO Recent Developments
- 4.10 HVRI
- 4.10.1 HVRI Company Information
- 4.10.2 HVRI Business Overview
- 4.10.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 HVRI Veterinary Biologics Product Portfolio
- 4.10.5 HVRI Recent Developments
- 4.11 Kyoto Biken
- 4.11.1 Kyoto Biken Company Information
- 4.11.2 Kyoto Biken Business Overview
- 4.11.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Kyoto Biken Veterinary Biologics Product Portfolio
- 4.11.5 Kyoto Biken Recent Developments
- 4.12 Ringpu Biology
- 4.12.1 Ringpu Biology Company Information
- 4.12.2 Ringpu Biology Business Overview
- 4.12.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ringpu Biology Veterinary Biologics Product Portfolio
- 4.12.5 Ringpu Biology Recent Developments
- 4.13 Vaksindo
- 4.13.1 Vaksindo Company Information
- 4.13.2 Vaksindo Business Overview
- 4.13.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Vaksindo Veterinary Biologics Product Portfolio
- 4.13.5 Vaksindo Recent Developments
- 4.14 Virbac
- 4.14.1 Virbac Company Information
- 4.14.2 Virbac Business Overview
- 4.14.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Virbac Veterinary Biologics Product Portfolio
- 4.14.5 Virbac Recent Developments
- 4.15 WINSUN
- 4.15.1 WINSUN Company Information
- 4.15.2 WINSUN Business Overview
- 4.15.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 WINSUN Veterinary Biologics Product Portfolio
- 4.15.5 WINSUN Recent Developments
- 4.16 Yebio
- 4.16.1 Yebio Company Information
- 4.16.2 Yebio Business Overview
- 4.16.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Yebio Veterinary Biologics Product Portfolio
- 4.16.5 Yebio Recent Developments
- 4.17 Zoetis
- 4.17.1 Zoetis Company Information
- 4.17.2 Zoetis Business Overview
- 4.17.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Zoetis Veterinary Biologics Product Portfolio
- 4.17.5 Zoetis Recent Developments
- 4.18 ChengDu Tecbond
- 4.18.1 ChengDu Tecbond Company Information
- 4.18.2 ChengDu Tecbond Business Overview
- 4.18.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
- 4.18.5 ChengDu Tecbond Recent Developments
- 4.19 Jinyu Bio-Technology
- 4.19.1 Jinyu Bio-Technology Company Information
- 4.19.2 Jinyu Bio-Technology Business Overview
- 4.19.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
- 4.19.5 Jinyu Bio-Technology Recent Developments
- 4.20 Merck
- 4.20.1 Merck Company Information
- 4.20.2 Merck Business Overview
- 4.20.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Merck Veterinary Biologics Product Portfolio
- 4.20.5 Merck Recent Developments
5 Global Veterinary Biologics Market Scenario by Region
- 5.1 Global Veterinary Biologics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Biologics Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Biologics Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Biologics Sales by Region: 2027-2032
- 5.3 Global Veterinary Biologics Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Biologics Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Biologics Revenue by Region: 2027-2032
- 5.4 North America Veterinary Biologics Market Facts & Figures by Country
- 5.4.1 North America Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Biologics Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Biologics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Veterinary Biologics Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Biologics Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Biologics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Veterinary Biologics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Biologics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Biologics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Biologics Market Facts & Figures by Country
- 5.7.1 South America Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Biologics Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Biologics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Biologics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Biologics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Veterinary Biologics Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Biologics Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Veterinary Biologics Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Biologics Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Biologics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Biologics Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Biologics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Biologics Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Biologics Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Veterinary Biologics Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Biologics Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Biologics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Biologics Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Biologics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Biologics Value Chain Analysis
- 8.1.1 Veterinary Biologics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Biologics Production Mode & Process
- 8.2 Veterinary Biologics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Biologics Distributors
- 8.2.3 Veterinary Biologics Customers
9 Global Veterinary Biologics Analyzing Market Dynamics
- 9.1 Veterinary Biologics Industry Trends
- 9.2 Veterinary Biologics Industry Drivers
- 9.3 Veterinary Biologics Industry Opportunities and Challenges
- 9.4 Veterinary Biologics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst